Unknown

Dataset Information

0

Maintenance therapy for chronic lymphocytic leukaemia

ABSTRACT: Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of maintenance therapy in individuals with chronic lymphocytic leukaemia (CLL).

SUBMITTER: Lee C 

PROVIDER: S-EPMC6848968 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Chronic lymphocytic leukaemia.
| S-EPMC5336551 | biostudies-literature
Unknown Immunotherapy in Chronic Lymphocytic Leukaemia (CLL).
| S-EPMC4796351 | biostudies-literature
Unknown Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.
| S-EPMC3152962 | biostudies-literature
Unknown Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.
| S-EPMC5923897 | biostudies-literature
Unknown A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
| S-EPMC6988939 | biostudies-literature
Unknown Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.
| S-EPMC5638689 | biostudies-literature
Unknown Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.
| S-EPMC5695391 | biostudies-literature
Unknown UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
| S-EPMC7374097 | biostudies-literature
Unknown Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
| S-EPMC6630176 | biostudies-literature
Unknown Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived.
| S-EPMC7072049 | biostudies-literature